These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33511656)

  • 21. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
    Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
    J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placenta specific protein-1 in recurrent pregnancy loss and in
    Yilmaz N; Timur H; Ugurlu EN; Yilmaz S; Ozgu-Erdinc AS; Erkilinc S; Inal HA
    J Obstet Gynaecol; 2020 Aug; 40(6):843-848. PubMed ID: 31791163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?
    Mekinian A; Cohen J; Alijotas-Reig J; Carbillon L; Nicaise-Roland P; Kayem G; Daraï E; Fain O; Bornes M
    Am J Reprod Immunol; 2016 Jul; 76(1):8-28. PubMed ID: 26847715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.
    Stricker RB; Winger EE
    Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and individual patient data meta-analyses of randomised clinical trials.
    Egerup P; Lindschou J; Gluud C; Christiansen OB
    Syst Rev; 2014 Aug; 3():89. PubMed ID: 25128005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.
    Ensom MH; Stephenson MD
    Hum Reprod; 2011 Sep; 26(9):2283-8. PubMed ID: 21771770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis.
    Daya S; Gunby J; Clark DA
    Am J Reprod Immunol; 1998 Feb; 39(2):69-76. PubMed ID: 9506204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
    Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
    Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
    Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
    J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin and recurrent pregnancy loss.
    Carp HJ; Sapir T; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):327-32. PubMed ID: 16391409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of New Immunological Therapeutic Strategies on Recurrent Miscarriage and Recurrent Implantation Failure.
    Parhizkar F; Motavalli-Khiavi R; Aghebati-Maleki L; Parhizkar Z; Pourakbari R; Kafil HS; Danaii S; Yousefi M
    Immunol Lett; 2021 Aug; 236():20-30. PubMed ID: 34090942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF).
    Clark DA; Coulam CB; Stricker RB
    J Assist Reprod Genet; 2006 Jan; 23(1):1-13. PubMed ID: 16421767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
    Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
    Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the T-helper 1 and 2 cell populations during pregnancy in tacrolimus-treated women with repeated implantation failure and recurrent pregnancy loss.
    Hisano M; Nakagawa K; Kwak-Kim J; Sugiyama R; Sago H; Yamaguchi K
    Hum Fertil (Camb); 2022 Dec; 25(5):975-982. PubMed ID: 34304683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent pregnancy losses and the role of immunotherapy.
    Omwandho CA; Tinneberg HR; Tumbo-Oeri AG; Roberts TK; Falconer J
    Arch Gynecol Obstet; 2000 Jul; 264(1):3-12. PubMed ID: 10985611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral and cellular autoimmunity in women with recurrent pregnancy losses and repeated implantation failures: A possible role of vitamin D.
    Kwak-Kim J; Skariah A; Wu L; Salazar D; Sung N; Ota K
    Autoimmun Rev; 2016 Oct; 15(10):943-7. PubMed ID: 27491565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss.
    Kim JH; Kim SH; Yang N; Ko Y; Lee SR; Chae HD
    J Korean Med Sci; 2022 Jun; 37(25):e200. PubMed ID: 35762143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment.
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Dolati S; Farzadi L; Ghasemzadeh A; Hamdi K; Younesi V; Nouri M; Yousefi M
    Syst Biol Reprod Med; 2017 Dec; 63(6):350-359. PubMed ID: 29099629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience.
    Coulam CB
    Am J Reprod Immunol; 1994 Dec; 32(4):286-9. PubMed ID: 7718095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study.
    Jablonowska B; Selbing A; Palfi M; Ernerudh J; Kjellberg S; Lindton B
    Hum Reprod; 1999 Mar; 14(3):838-41. PubMed ID: 10221723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.